Menezes Ronald 4
4 · Beauty Health Co · Filed Mar 24, 2026
Research Summary
AI-generated summary of this filing
Beauty Health (SKIN) CRO Ronald Menezes Receives RSU Award
What Happened
Ronald Menezes, Chief Revenue Officer of Beauty Health Co (SKIN), received a grant of 746,681 restricted stock units (RSUs) on March 20, 2026. The Form 4 lists the transaction as an award/acquisition (code A); no purchase price or immediate cash value is reported because these are time‑based RSUs, not an open‑market buy or sale.
Key Details
- Transaction date: 2026-03-20 (reported on Form 4 filed 2026-03-24). Filing appears timely under Form 4 rules.
- Shares/units granted: 746,681 RSUs. Price: N/A (RSUs, not a purchase).
- Shares owned after transaction: Not specified in the filing.
- Footnote: RSUs convert to one share of Class A common stock each and vest in one‑third increments on each of the first three anniversaries of the grant date (3/20/2026), subject to continued service and certain acceleration rights.
Context
RSU grants are compensation awards and do not reflect an immediate market purchase or sale. Vesting over three years means the shares will be delivered (and potentially taxable) only as portions vest, provided Menezes remains employed or meets any acceleration conditions. This is a routine executive compensation action rather than a direct signal of buying or selling.
Insider Transaction Report
- Award
Class A Common Stock
[F1]2026-03-20+746,681→ 1,759,915 total
Footnotes (1)
- [F1]Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock of The Beauty Health Company (the "Company"). The RSUs are subject to time-vesting conditions. The RSUs vest in one-third increments on each of the first three anniversaries of the grant date of March 20, 2026, in each case subject to continued service with the Company through the vesting date and certain acceleration rights.